Mirre Scholte (M Scholte)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Insulin Resistance

Minimally Invasive

Top Venues

PharmacoEconomics

BMJ surgery, interventions, & health technologies

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

The British journal of surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Mirre Scholte, Bram Ramaekers, Evangelos Danopoulos, Sabine E Grimm, Andrea Fernandez Coves, Xiaoyu Tian, Thomas Debray, Jiongyu Chen, Lisa Stirk, Rachel Croft, Manuela Joore, Nigel Armstrong
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. PharmacoEconomics 42 (8) (2024)
Mirre Scholte, Bram Ramaekers, Evangelos Danopoulos, Sabine E Grimm, Andrea Fernandez Coves, Xiaoyu Tian, Thomas Debray, Jiongyu Chen, Lisa Stirk, Rachel Croft, Manuela Joore, Nigel Armstrong
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. PharmacoEconomics (2024)
Mirre Scholte, Bram Ramaekers, Evangelos Danopoulos, Sabine E Grimm, Andrea Fernandez Coves, Xiaoyu Tian, Thomas Debray, Jiongyu Chen, Lisa Stirk, Rachel Croft, Manuela Joore, Nigel Armstrong
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. PharmacoEconomics 42 (8) (2024)
Mirre Scholte, Bram Ramaekers, Evangelos Danopoulos, Sabine E Grimm, Andrea Fernandez Coves, Xiaoyu Tian, Thomas Debray, Jiongyu Chen, Lisa Stirk, Rachel Croft, Manuela Joore, Nigel Armstrong
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective. PharmacoEconomics 42 (8) (2024)
Bastiaan R Klarenbeek, Hitoshi Fujiwara, Mirre Scholte, Maroeska M Rovers, Atsushi Shiozaki, Camiel Rosman
Introduction of Minimally Invasive transCervical oEsophagectomy (MICE) according to the IDEAL framework. The British journal of surgery (2023)
Mirre Scholte, Kas Woudstra, Janneke P C Grutters, Gerjon Hannink, Marcia Tummers, Rob P B Reuzel, Maroeska M Rovers
Towards early and broad evaluation of innovative surgical devices: integrating evidence synthesis, stakeholder involvement, and health economic modeling into the clinical research stages of the IDEAL framework. BMJ surgery, interventions, & health technologies 4 (1) (2022)
Mirre Scholte, Didi Jjm de Gouw, Bastiaan R Klarenbeek, Janneke Pc Grutters, Camiel Rosman, Maroeska M Rovers
Selecting esophageal cancer patients for lymphadenectomy after neoadjuvant chemoradiotherapy: a modeling study. BMJ surgery, interventions, & health technologies 2 (1) (2020)
Didi Jjm de Gouw, Mirre Scholte, Suzanne S Gisbertz, Bas P L Wijnhoven, Maroeska M Rovers, Bastiaan R Klarenbeek, Camiel Rosman
Extent and consequences of lymphadenectomy in oesophageal cancer surgery: case vignette survey. BMJ surgery, interventions, & health technologies 2 (1) (2020)
Mirre Scholte, Mayke A Hentschel, Gerjon Hannink, Henricus P M Kunst, Stefan C Steens, Maroeska M Rovers, Janneke P C Grutters
In search of the most cost-effective monitoring strategy for vestibular schwannoma: A decision analytical modelling study. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 44 (4) (2019)
Mirre Scholte, Mayke A Hentschel, Henricus P M Kunst, Stefan Steens, Maroeska M Rovers, Janneke P C Grutters
Potential savings in the diagnosis of vestibular schwannoma. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 43 (1) (2017)